azacitidine for
- Product NDC
- 69097-805
- 11-digit product format
- 690970805
- Labeler code
- 69097
- Product ID
- 69097-805_c5dc2bd3-9762-46f7-a2c7-7a9c6f951ea2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Cipla USA Inc.
- Application
- ANDA207518
- Marketing category
- ANDA
- Marketing start
- 2019-03-26
- Marketing end
- 0000-00-00
- Substance
- AZACITIDINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-805 | AZACITIDINE FOR (AZACITIDINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CIPLA USA INC.] | 5 | Legacy NDC | 20230301_52b19d87-b646-4a00-bdd4-ac826860b719.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-805-40 | 69097080540 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (69097-805-40) | 2019-03-26 | 0000-00-00 | No | No | Current |